According to a market report by Lucintel, the future of the global knee cartilage repair market looks promising with opportunities in the hospital, ambulatory surgical center, and independent center markets. The global knee cartilage repair market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 15.3% from 2024 to 2030. The major drivers for this market are the increasing incidence of osteoarthritis, growing technological advancement in cartilage repair treatment, and improved healthcare infrastructure.

A more than 150 – page report is developed to understand trends, opportunity and forecast in knee cartilage repair market to 2030 by treatment (cell-based and non-cell-based), devices (implants, osteotomy, bone grafts, arthroscopy, resurfacing, arthrodesis), application (osteoarthritis, rheumatoid arthritis, osteonecrosis, fractures, bone tumors), end use (hospital, ambulatory surgical centers, and independent centers), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, cell-based and non-cell-based are the major segments of knee cartilage repair market by treatment. Lucintel forecasts that cell-based will remain the largest segment due to the growing investment in healthcare and advancement in medical technologies.

Within this market, hospitals will remain the largest segment over the forecast period due to increasing patient volume in the hospital for knee cartilage repair and growing investments in healthcare infrastructure.

North America will remain the largest region due to increasing prevalence of knee injuries and osteoarthritis in the region.

B. Braun Melsungen, Isto Technologies, Smith & Nephew, Stryker, and Zimmer Biomet are the major suppliers in the knee cartilage repair market.






This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]